Illness	Number of cases
Malignant neoplasm of prostate (C61)	208
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9)	165
Hyperplasia of prostate (N40)	122
Calculus of kidney and ureter - Calculus of kidney (N20.0)	81
Calculus of kidney and ureter - Calculus of ureter (N20.1)	61
Malignant neoplasm of kidney except renal pelvis (C64)	48
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	45
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	41
Obstructive and reflux uropathy (N13.3)	28
Hydrocele and spermatocele - Hydrocele unspecified (N43.3)	26

Top 10 treatments

Treatment	Number
(1-999.40)	749
Examination of the urethra and the urinary bladder by endoscopy (1-661)	738
Injection or administration of medicines into the urinary bladder (8-132.3)	459
Operation using a surgical robot (5-987.0)	273
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	173
Surgical removal of the prostate, of the seminal vesicle and the associated lymph nodes (5-604.52)	139
Insertion, exchange or removal of a ureteral stent (8-137.00)	137
Insertion, exchange or removal of a ureteral stent (8-137.10)	127
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	120
Examination of the ureter by endoscopy (1-665)	116

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Mixed main and occupancy ward

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
83	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
75	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
75	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Doctoral supervision